Consistently, SHQA treatment increased UCP1 protein levels (Fig. 6B), suggesting that SHQA-induced thermogenic signaling in WAT contributes to its anti-obesity effect. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.